MCID: MYX013
MIFTS: 32

Myxofibrosarcoma malady

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Myxofibrosarcoma

About this section
Sources:
52Orphanet, 29ICD10 via Orphanet
See all MalaCards sources

Aliases & Descriptions for Myxofibrosarcoma:

Name: Myxofibrosarcoma 52
Myxoid Malignant Fibrous Histiocytoma 52
 
Fibromyxosarcoma 52

Characteristics:

Orphanet epidemiological data:

52
myxoid malignant fibrous histiocytoma:
Inheritance: Not applicable; Age of onset: Adult

Classifications:



External Ids:

Orphanet52 ORPHA79105
ICD10 via Orphanet29 C49.9

Summaries for Myxofibrosarcoma

About this section
Wikipedia:69 A histiocytoma is a tumour consisting of histiocytes. Histiocytes are cells that are a part of the... more...

MalaCards based summary: Myxofibrosarcoma, also known as myxoid malignant fibrous histiocytoma, is related to absence of fingerprints congenital milia and cerebrovascular disease. An important gene associated with Myxofibrosarcoma is CREB3L2 (CAMP Responsive Element Binding Protein 3 Like 2), and among its related pathways are Vasopressin-regulated water reabsorption and AMPK signaling pathway. Affiliated tissues include heart, skin and breast.

Related Diseases for Myxofibrosarcoma

About this section

Diseases related to Myxofibrosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 58)
idRelated DiseaseScoreTop Affiliating Genes
1absence of fingerprints congenital milia10.5DES, S100B
2cerebrovascular disease10.5DES, S100B
3lymphangiosarcoma10.5DES, S100B
4chondroblastoma10.5DES, S100B
5subacute leukemia10.5DES, S100B
6pulmonary venoocclusive disease10.5DES, S100B
7bartholin's gland benign neoplasm10.5DES, S100B
8malignant adenofibroma10.5DES, S100B
9sclerosing liposarcoma10.5DES, S100B
10skin glomangioma10.5DES, S100B
11pauciarticular onset juvenile idiopathic arthritis10.3CD36, S100B
12focal chorioretinitis10.3DES, MKI67
13pura syndrome10.3DES, MKI67
14anus leiomyosarcoma10.3DES, S100B
15gangliocytoma10.3DES, MKI67
16megarbane jalkh syndrome10.3DES, S100B
17renal tubular acidosis, distal, autosomal recessive10.2DES, S100B
18sarcoma10.2
19novak syndrome10.2MKI67, S100B
20osteogenesis imperfecta, type ii10.2CD36, CREB3L1
21polyomavirus allograft nephropathy10.2MKI67, S100B
22myopathy10.1DES, S100B
23epidural neoplasm10.1CREB3L2, DES
24liposarcoma10.1
25emerinopathy10.0DES, MKI67, S100B
26mixed extragonadal germ cell cancer10.0DES, MKI67, S100B
27undifferentiated pleomorphic sarcoma10.0
28gastrointestinal stromal tumor10.0DES, MKI67, S100B
29angora hair nevus10.0DES, FUS
30gallbladder leiomyosarcoma9.9CREB3L2, DES, S100B
31myxoid liposarcoma9.9
32burn scar9.9
33burns9.9
34histiocytoma9.9
35fibrous histiocytoma9.9
36neutrophil immunodeficiency syndrome9.8DES, S100B
37median neuropathy9.8CREB3L2, FUS
38prostate cancer9.8
39dermatofibrosarcoma protuberans9.8
40congestive heart failure9.8
41fibroma9.8
42prostatitis9.8
43cervicitis9.8
44fibrosarcoma9.8
45cerebritis9.8
46thyroiditis9.8
47meningitis9.8
48dedifferentiated liposarcoma9.8
49spindle cell liposarcoma9.8CREB3L2, FUS
50cholelithiasis9.7CREB3L2, FUS

Graphical network of the top 20 diseases related to Myxofibrosarcoma:



Diseases related to myxofibrosarcoma

Symptoms for Myxofibrosarcoma

About this section

Drugs & Therapeutics for Myxofibrosarcoma

About this section

Drugs for Myxofibrosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DoxilApproved June 1999Phase 2, Phase 3167631703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
2Isophosphamide mustardPhase 2, Phase 3386
3
MechlorethaminePhase 2, Phase 336351-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
 
KBioGR_001448
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
╬▓,╬▓'-dichlorodiethyl-N-methylamine
4Alkylating AgentsPhase 2, Phase 34573
5
IfosfamidePhase 2, Phase 33863778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide (JAN/USP/INN)
 
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
6
DoxorubicinPhase 2, Phase 3167623214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
7
CyclophosphamidePhase 2, Phase 3275650-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
8razoxanePhase 239
9
DexrazoxanePhase 23924584-09-671384
Synonyms:
(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione
(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane
(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane
(S)-(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane
149003-01-0
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)- (9CI)
24584-09-6
4,4'-(2S)-propane-1,2-diyldipiperazine-2,6-dione
4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione
4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione hydrochloride
AC1L2G28
AC1OCF6D
AC1Q6LVI
ADR 529
BIDD:GT0068
BRN 5759131
C11H16N4O4
CHEBI:50223
CHEBI:50224
CHEMBL1200778
CHEMBL1738
CID6918223
CID71384
Cardioxane
D03730
D07807
DB00380
DB02444
Desrazoxane
Dexrazoxan
Dexrazoxane
Dexrazoxane (TN)
Dexrazoxane (USAN/INN)
Dexrazoxane HCl
Dexrazoxane [USAN:BAN:INN]
Dexrazoxane hydrochloride
 
Dexrazoxano
Dexrazoxano [INN-Spanish]
Dexrazoxanum
Dexrazoxanum [INN-Latin]
Dextrorazoxane
Dyzoxane
Eucardion
HSDB 7319
I06-1989
I14-10061
ICRF 187
ICRF 187 hydrochloride
ICRF-187
Icrf-187
LS-111911
NCI60_001367
NSC 169780
NSC169780
Razoxana [INN-Spanish]
Razoxane
Razoxane, (S)-Isomer
Razoxanum [INN-Latin]
Razoxin
S1222_Selleck
Savene
Soluble ICRF (L-isosomer)
Tepirone
TopoTect
Totect
Totect (TN)
Totect, ICRF-187, Zinecard, Cardioxane, Dexrazoxane Hydrochloride
Troxozone
UNII-048L81261F
UNII-5346058Q7S
Zinecard
Zinecard (TN)
dyzoxane
icrf-187

Interventional clinical trials:

idNameStatusNCT IDPhase
1Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryRecruitingNCT02180867Phase 2, Phase 3
2Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic SarcomaRecruitingNCT02601209Phase 1, Phase 2
3Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaRecruitingNCT02584309Phase 2
4Alisertib in Treating Patients With Advanced or Metastatic SarcomaSuspendedNCT01653028Phase 2

Search NIH Clinical Center for Myxofibrosarcoma

Genetic Tests for Myxofibrosarcoma

About this section

Anatomical Context for Myxofibrosarcoma

About this section

MalaCards organs/tissues related to Myxofibrosarcoma:

34
Heart, Skin, Breast, Lung, Brain, Prostate, Skeletal muscle

Animal Models for Myxofibrosarcoma or affiliated genes

About this section

Publications for Myxofibrosarcoma

About this section

Articles related to Myxofibrosarcoma:

(show top 50)    (show all 168)
idTitleAuthorsYear
1
Giant myxofibrosarcoma of the orbit: a rare case and a review of the literature. (27298287)
2016
2
Integrin-I+10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma. (27577794)
2016
3
A Case of Myxofibrosarcoma in an Unusual Thoracic Location. (26933417)
2016
4
Tail of Superficial Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma After Preoperative Radiotherapy. (27127141)
2016
5
Myxofibrosarcoma presenting as an exophytic, multi-lobed nodule on the leg. (27617600)
2016
6
Myxofibrosarcoma - Case report. (26982788)
2016
7
Coronary thrombus aspiration revealed tumorous embolism of myxofibrosarcoma from the left atrium. (25711731)
2015
8
Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study. (24491153)
2014
9
Very rare case of large obstructive myxofibrosarcoma of the right ventricle assessed with multi-diagnostic imaging techniques. (24694488)
2014
10
Appearance of recurrent cardiac myxofibrosarcoma on FDG PET/CT. (24662649)
2014
11
MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value. (24889995)
2014
12
AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance. (25384383)
2014
13
CD34-positive superficial myxofibrosarcoma: a potential diagnostic pitfall. (23600956)
2013
14
Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging. (23318907)
2013
15
ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance. (23549872)
2013
16
Primary cardiac myxofibrosarcoma: a case report and review of the literature. (23389377)
2012
17
Myxofibrosarcoma of the orbit: case report and review of literature. (21464787)
2012
18
Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeutics. (22322669)
2012
19
18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall. (23250511)
2012
20
Myxofibrosarcoma of the sinus piriformis: case report and literature review. (23152982)
2012
21
Myxofibrosarcoma: cytomorphologic findings and differential diagnosis on fine needle aspiration. (22236741)
2012
22
Myxofibrosarcoma of the infratemporal space. (21768709)
2011
23
Epitheloid myxofibrosarcoma of the parotid gland. (22937388)
2011
24
Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. (20878245)
2011
25
Low-grade myxofibrosarcoma presenting at the site of prior high-grade disease. (21752050)
2011
26
Fine-needle aspiration in myxofibrosarcoma: experience of Institut Curie. (19899126)
2010
27
Primary myxofibrosarcoma of the parotid: case report. (20513245)
2010
28
CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma. (20175824)
2010
29
Myxofibrosarcoma of the orbit: a clinicopathologic case report. (20305519)
2010
30
Palliation of recurrent myxofibrosarcoma with radiotherapy and hyperthermia. (21140105)
2010
31
Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis. (20639860)
2010
32
Primary aortic myxofibrosarcoma mimicking thrombus: findings on CT, MRI, and angiography. (19465836)
2009
33
Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. (19320777)
2009
34
High-grade infiltrative myxofibrosarcoma in the forearm presenting as acute carpal tunnel syndrome. (18294554)
2008
35
Myxofibrosarcoma in the skin. (18494817)
2008
36
Radiation-induced intra- and extra-cranial high-grade myxofibrosarcoma with tumor bleeding. (18701294)
2008
37
Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation. (16751306)
2006
38
Primary cutaneous myxofibrosarcoma mimicking pleomorphic hyalinizing angiectatic tumor (PHAT): a potential diagnostic pitfall. (16121054)
2005
39
Establishment and characterization of a novel myxofibrosarcoma cell line. (16080955)
2005
40
Minichromosome maintenance protein in myxofibrosarcoma. (14685255)
2004
41
Altered expression of cell cycle regulators in myxofibrosarcoma, with special emphasis on their prognostic implications. (14608538)
2003
42
Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms. (12876484)
2003
43
The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma. (11213831)
2001
44
Translocation (2;15)(p23;q21.2) and interstitial deletion of 7q in a case of low-grade myxofibrosarcoma. (11425453)
2001
45
Low-grade myxofibrosarcoma: progression in recurrence. (9088034)
1997
46
Brain metastasis from myxofibrosarcoma of the heart. (9059719)
1997
47
Myxofibrosarcoma of the maxillary sinus. (7067862)
1982
48
Myxofibrosarcoma: a correlative cytologic and histologic study of 13 cases examined by fine needle aspiration cytology. (6154396)
1980
49
The ultrastructure of myxofibrosarcoma. A study of 11 cases. (154761)
1979
50
Central myxofibrosarcoma of the mandible treated by radical resection. (1056575)
1975

Variations for Myxofibrosarcoma

About this section

Copy number variations for Myxofibrosarcoma from CNVD:

6 (show all 47)
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1297051234600000241700000LossAKT3Myxofibrosarcoma
23887510105700000114900000LossFACL5Myxofibrosarcoma
33942310114900000127400000LossDMBT1Myxofibrosarcoma
4426871038000006700000LossDNMT2Myxofibrosarcoma
5478031098000000105700000LossHOX11Myxofibrosarcoma
6478051098000000105700000LossPLAUMyxofibrosarcoma
74968711110000000120700000LossPIG8Myxofibrosarcoma
85175711130300000134452384LossADAMTS8Myxofibrosarcoma
954382114340000048800000LossKAI1Myxofibrosarcoma
106147412114800000GainCCND2Myxofibrosarcoma
116152212133200000LossLRP6Myxofibrosarcoma
1266186122630000033200000GainKRAGMyxofibrosarcoma
1370913126600000069800000GainHMGICMyxofibrosarcoma
1473112129120000094800000LossBTG1Myxofibrosarcoma
15108897172320000035400000LossLIG3Myxofibrosarcoma
16115128175490000059900000GainTBX2Myxofibrosarcoma
171241761916900000GainSH3GL1Myxofibrosarcoma
1814368122390000031900000LossALKMyxofibrosarcoma
19147727269800000136600000LossCXCR4Myxofibrosarcoma
2014830327540000083700000LossREG1AMyxofibrosarcoma
21151117201780000027100000LossJAG1Myxofibrosarcoma
221708943161200000184200000LossMDS1Myxofibrosarcoma
2317756735850000063700000LossFHITMyxofibrosarcoma
24186568436900000114100000LossIBSPMyxofibrosarcoma
2518754145070000052400000GainAFPMyxofibrosarcoma
262080646164400000170899992LossPDCD2Myxofibrosarcoma
272178487104755715105039798AmplificationlicationSRPK2Myxofibrosarcoma
282179237105888733105925638AmplificationlicationPBEF1Myxofibrosarcoma
292181147107788083108096826AmplificationlicationNRCAMMyxofibrosarcoma
302186927116312458116438439AmplificationlicationMETMyxofibrosarcoma
312190527121513158121702088AmplificationlicationPTPRZ1Myxofibrosarcoma
322192577124462440124570037AmplificationlicationPOT1Myxofibrosarcoma
332194807127292201127732658AmplificationlicationSND1Myxofibrosarcoma
342199537132400000147500000GainTIM1Myxofibrosarcoma
35223288718554272272583Amplificationlicatio nMAD1L1Myxofibrosarcoma
3622554874731475247621742AmplificationTNS3Myxofibrosarcoma
3722804477324519273247014Amplificationlicatio nCLDN4Myxofibrosarcoma
3822877278133144481399452Amplificationlicatio nHGFMyxofibrosarcoma
3922910478725772887461612Amplificationlicatio nRPIP9Myxofibrosarcoma
4022933279009573790839904Amplificationlicatio nPFTK1Myxofibrosarcoma
4122960079223423692465941Amplificationlicatio nCDK6Myxofibrosarcoma
422349538140000000146274826GainTGMyxofibrosarcoma
432423858720000043200000GainPOLBMyxofibrosarcoma
4426215003150000037500000GainOTCMyxofibrosarcoma
4526443206510000067700000GainED1Myxofibrosarcoma
4626454606770000072200000GainTEDMyxofibrosarcoma
47266520098200000110500000LossPLPMyxofibrosarcoma

Expression for genes affiliated with Myxofibrosarcoma

About this section
Search GEO for disease gene expression data for Myxofibrosarcoma.

Pathways for genes affiliated with Myxofibrosarcoma

About this section

Pathways related to Myxofibrosarcoma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7CREB3L1, CREB3L2
2
Show member pathways
9.1CD36, CREB3L1, CREB3L2

GO Terms for genes affiliated with Myxofibrosarcoma

About this section

Biological processes related to Myxofibrosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulum unfolded protein responseGO:00309689.7CREB3L1, CREB3L2

Molecular functions related to Myxofibrosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cAMP response element bindingGO:00354979.7CREB3L1, CREB3L2

Sources for Myxofibrosarcoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet